Stuve-Wiedemann syndrome 1 (STWS1) is a rare autosomal recessive bent-bone dysplasia caused by biallelic loss-of-function variants in LIFR, which encodes the leukemia inhibitory factor receptor. Failed LIF/CNTF-family gp130–JAK–STAT3 signaling in chondrocytes and autonomic/sensory neurons produces congenital bowing of the long bones with osteopenia, camptodactyly, and a life-threatening neonatal dysautonomia (temperature instability, swallowing dysfunction, and respiratory distress). Historically labeled neonatal Schwartz-Jampel syndrome type 2, it is genetically and mechanistically distinct from HSPG2/perlecan Schwartz-Jampel syndrome.
Ask a research question about LIFR-Related Stuve-Wiedemann Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from LIFR-Related Stuve-Wiedemann Syndrome:
name: LIFR-Related Stuve-Wiedemann Syndrome
creation_date: "2026-08-20T02:56:36Z"
category: Mendelian
description: >-
Stuve-Wiedemann syndrome 1 (STWS1) is a rare autosomal recessive bent-bone
dysplasia caused by biallelic loss-of-function variants in LIFR, which
encodes the leukemia inhibitory factor receptor. Failed LIF/CNTF-family
gp130–JAK–STAT3 signaling in chondrocytes and autonomic/sensory neurons
produces congenital bowing of the long bones with osteopenia, camptodactyly,
and a life-threatening neonatal dysautonomia (temperature instability,
swallowing dysfunction, and respiratory distress). Historically labeled
neonatal Schwartz-Jampel syndrome type 2, it is genetically and
mechanistically distinct from HSPG2/perlecan Schwartz-Jampel syndrome.
disease_term:
preferred_term: Stuve-Wiedemann syndrome 1
term:
id: MONDO:0800043
label: Stüve-Wiedemann syndrome 1
parents:
- hereditary disease
- Skeletal Dysplasia
synonyms:
- STWS
- STWS1
- Stuve-Wiedemann Syndrome 1
- Stüve-Wiedemann syndrome 1
- Stuve-Wiedemann syndrome, LIFR-related
- Stuve-Wiedemann syndrome
- Stüve-Wiedemann syndrome
- Stüve-Wiedemann dysplasia
- Schwartz-Jampel syndrome type 2
- neonatal Schwartz-Jampel syndrome
- SJS2
notes: >-
NAMING: this entry is gene-anchored because "Stuve-Wiedemann syndrome" alone is
locus-ambiguous — it names two diseases, LIFR and IL6ST. The OMIM/MONDO numbering
(STWS1 / STWS2) is retained in `synonyms` and remains the `disease_term` label, but
the entry name says which gene, following the same rule applied to the two kyphomelic
dysplasia entries in the same ISDS group. The rule is not an adoption of the
ISDS 2023 dyadic naming system; it is disambiguation, applied only where one
phenotypic label names more than one dismech entry.
LUMP/SPLIT: this entry models only LIFR-related Stuve-Wiedemann syndrome 1
(MONDO:0800043; OMIM:601559). The IL6ST-related phenocopy Stuve-Wiedemann
syndrome 2 (MONDO:0030756; OMIM:619751; "extended Stuve-Wiedemann syndrome"
in Chen et al., PMID:31914175) is curated as a separate entry
(kb/disorders/IL6ST-Related_Stuve-Wiedemann_Syndrome.yaml) because gp130 (IL6ST) is the shared
co-receptor for many IL-6-family cytokines, complete IL6ST loss abolishes
IL-6/IL-11/IL-27/OSM/LIF responses rather than LIFR-selective signaling, and
the ISDS 2023 bent-bone group lists "Stuve-Wiedemann dysplasia (LIFR)"
specifically. The parent grouping MONDO:0031280 is recorded as a broadMatch,
not as the primary disease_term. This entity must not be folded into
Schwartz-Jampel syndrome (HSPG2/perlecan; kb/disorders/Schwartz-Jampel_Syndrome.yaml).
No dedicated GeneReviews chapter was found (PubMed searches
"Stuve-Wiedemann GeneReviews[All Fields]" and "LIFR GeneReviews"; the sole
GeneReviews-tagged hit, PMID:40521311, is a prenatal ultrasound series that
searched GeneReviews as a literature source, not a GeneReviews chapter).
Orphanet structured cache for ORPHA:3206 could not be rebuilt in this
worktree (en_product1.xml not present); prevalence is recorded from the
published case literature rather than an Orphanet epidemiology class.
Mikelonis et al. 2014 (PMID:24618404) prints OMIM # 610559 in the abstract;
the canonical OMIM phenotype number for LIFR-related STWS is 601559
(Warnier et al. 2022; MONDO xref).
mappings:
mondo_mappings:
- term:
id: MONDO:0031280
label: Stuve-Wiedemann syndrome
mapping_predicate: skos:broadMatch
mapping_source: MONDO
mapping_justification: >-
MONDO:0031280 is the parent grouping that also includes IL6ST-related
Stuve-Wiedemann syndrome 2 (MONDO:0030756). This entry is restricted to
the LIFR disease (MONDO:0800043).
classifications:
harrisons_chapter:
- classification_value: GENETICS_ENVIRONMENT_DISEASE
notes: >-
Hereditary skeletal dysplasia (ISDS bent-bone group); Harrison's
genetics/heritable-disease Part rather than an organ-system Part.
Neonatal autonomic/respiratory crises are prominent but are modeled as
mechanism and phenotype, not as additional Harrison's Parts.
isds_skeletal_category:
- classification_value: bent_bone_dysplasia
notes: >-
ISDS Nosology of Genetic Skeletal Disorders, 2023 revision (11th edition;
Unger et al., PMID:36779427), group 20 "Bent bones dysplasia group",
entry NOS 20-0020, listed there as "Stuve-Wiedemann syndrome, LIFR-related"
(AR, LIFR, MIM 601559). The 2023 row carries the comment "Includes former
neonatal Schwartz-Jampel syndrome or SJS type 2", which is the committee
endorsing the historical synonymy this entry records — and, by placing
it here rather than with HSPG2 Schwartz-Jampel syndrome, endorsing the
split from that disorder too. In the 2019 revision (PMID:31633310) the
same group was numbered 18 and the entry was worded "Stuve-Wiedemann
dysplasia (LIFR)". The 2023 table lists the IL6ST-related form separately
as NOS 20-0030, which is why dismech curates it as its own entry
(kb/disorders/IL6ST-Related_Stuve-Wiedemann_Syndrome.yaml) rather than folding it in
here. Placement is recorded from the nosology table rather than from an
abstract-quotable sentence.
inheritance:
- name: Autosomal recessive inheritance
description: >-
STWS1 segregates as an autosomal recessive trait; affected individuals
carry biallelic (homozygous or compound heterozygous) LIFR loss-of-function
variants and heterozygous parents are unaffected.
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality.
explanation: >-
Landmark gene-identification paper states autosomal recessive inheritance
as part of the defining clinical description.
pathophysiology:
- name: Biallelic LIFR Loss of Function
biological_scale: MOLECULAR
description: >-
Biallelic LIFR null or truncating variants destabilize the transcript and
prevent formation of functional leukemia inhibitory factor receptor,
removing the ligand-specific chain of the LIFR–gp130 heterodimer.
genetic_context:
functional_impact_category: LOSS_OF_FUNCTION
variant_origin: GERMLINE
allelic_hit_role: BIALLELIC_INACTIVATION
description: >-
Homozygous or compound-heterozygous germline loss-of-function alleles
(frameshift, nonsense, splice, or other null) of LIFR.
genes:
- preferred_term: LIFR
term:
id: hgnc:6597
label: LIFR
molecular_functions:
- preferred_term: leukemia inhibitory factor receptor activity
term:
id: GO:0004923
label: leukemia inhibitory factor receptor activity
modifier: LOSS_OF_FUNCTION
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
A total of 14 distinct mutations were identified in the 19 families.
explanation: >-
Establishes LIFR as the causal gene across a multi-family SWS/SJS2 series.
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Functional studies indicated that these mutations alter the stability of LIFR messenger RNA transcripts, resulting in the absence of the LIFR protein and in the impairment of the JAK/STAT3 signaling pathway in patient cells.
explanation: >-
Patient-cell assays show that the alleles are null at the mRNA and protein
level, not merely mapping hits.
downstream:
- target: Failed LIF-Family gp130 JAK-STAT3 Signaling
- name: Failed LIF-Family gp130 JAK-STAT3 Signaling
biological_scale: CELLULAR
description: >-
Without LIFR, LIF and related IL-6-family ligands cannot assemble a
productive LIFR–gp130 receptor complex, so JAK-mediated STAT3 signaling
(and associated MAPK/PI3K output) fails in target cells. This is
LIFR-selective; complete IL6ST/gp130 loss abolishes a broader cytokine
set and is modeled separately as STWS2.
biological_processes:
- preferred_term: leukemia inhibitory factor signaling pathway
term:
id: GO:0048861
label: leukemia inhibitory factor signaling pathway
modifier: LOSS_OF_FUNCTION
- preferred_term: JAK-STAT cascade
term:
id: GO:0007259
label: cell surface receptor signaling pathway via JAK-STAT
modifier: DECREASED
- preferred_term: cytokine-mediated signaling pathway
term:
id: GO:0019221
label: cytokine-mediated signaling pathway
modifier: DECREASED
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Functional studies indicated that these mutations alter the stability of LIFR messenger RNA transcripts, resulting in the absence of the LIFR protein and in the impairment of the JAK/STAT3 signaling pathway in patient cells.
explanation: >-
Direct functional readout that LIFR-null patient cells fail JAK/STAT3
signaling.
- reference: PMID:24618404
reference_title: "Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
LIFR signaling usually follows the JAK/STAT3 pathway, and is initiated by several interleukin-6-type cytokines.
explanation: >-
Review statement placing LIFR in the IL-6-family JAK/STAT3 cascade that
this node represents.
downstream:
- target: Impaired Chondrogenesis and Bone Remodeling
- target: Autonomic and Sensory Neuron Dysfunction
- name: Impaired Chondrogenesis and Bone Remodeling
biological_scale: TISSUE
conforms_to: "osteoporosis_bone_resorption#Increased Osteoclastic Bone Resorption"
description: >-
Failed LIF-family signaling in the developing skeleton reduces bone volume
and shifts remodeling toward osteoclast excess, producing congenital
camptomelia, cortical thickening with flared osteopenic metaphyses, and
later fractures and spinal deformity in survivors.
cell_types:
- preferred_term: chondrocyte
term:
id: CL:0000138
label: chondrocyte
- preferred_term: osteoclast
term:
id: CL:0000092
label: osteoclast
- preferred_term: osteoblast
term:
id: CL:0000062
label: osteoblast
biological_processes:
- preferred_term: skeletal system development
term:
id: GO:0001501
label: skeletal system development
modifier: DECREASED
- preferred_term: osteoclast differentiation
term:
id: GO:0030316
label: osteoclast differentiation
modifier: INCREASED
- preferred_term: Bone Resorption
term:
id: GO:0045453
label: bone resorption
modifier: INCREASED
evidence:
- reference: PMID:7789261
reference_title: Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Fetal bone volume is reduced greater than three-fold and the number of osteoclasts is increased six-fold, resulting in severe osteopenia of perinatal bone.
explanation: >-
Lifr-null mice provide the skeletal remodeling readout (low bone volume,
osteoclast excess, osteopenia) underlying the human bent-bone phenotype.
Not used as sole support for human phenotypes.
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality.
explanation: >-
Human radiographic signature of the skeletal arm of this node.
downstream:
- target: Bowed Long Bones
- target: Camptodactyly
- target: Recurrent Fractures
- target: Scoliosis
- target: Osteopenia
- target: Growth Delay
- target: Talipes
- target: Intrauterine Growth Retardation
- name: Autonomic and Sensory Neuron Dysfunction
biological_scale: TISSUE
description: >-
Failed LIF/CNTF-family signaling in autonomic and sensory neurons produces
the dysautonomia that dominates neonatal lethality: temperature instability
with hyperthermic crises, abnormal sweating, reduced pain sensation,
absent corneal and tendon reflexes, and swallowing/respiratory failure.
This is not the perlecan/AChE neuromuscular-junction mechanism of
Schwartz-Jampel syndrome.
cell_types:
- preferred_term: autonomic neuron
term:
id: CL:0000107
label: autonomic neuron
- preferred_term: sensory neuron
term:
id: CL:0000101
label: sensory neuron
- preferred_term: sympathetic neuron
term:
id: CL:0011103
label: sympathetic neuron
biological_processes:
- preferred_term: autonomic nervous system development
term:
id: GO:0048483
label: autonomic nervous system development
modifier: DECREASED
evidence:
- reference: PMID:28058407
reference_title: Neuropathies of Stüve-Wiedemann Syndrome due to mutations in leukemia inhibitory factor receptor (LIFR) gene.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Stüve-Wiedemann syndrome (STWS; OMIM # 610559) is a rare disease that results in dysfunction of the autonomic nervous system, which controls involuntary processes such as breathing rate and body temperature.
explanation: >-
Neuropathy-focused review identifies autonomic failure (breathing and
temperature) as the neural arm of LIFR-related STWS. The abstract's
OMIM # 610559 is the known Mikelonis typo; the disease identity is LIFR.
- reference: PMID:7789261
reference_title: Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Astrocyte numbers are reduced in the spinal cord and brain stem.
explanation: >-
Lifr-null mice show a neural developmental deficit, supporting a
nervous-system requirement for LIFR; they do not fully model human
dysautonomic crises in survivors.
downstream:
- target: Temperature Instability
- target: Feeding Difficulties
- target: Neonatal Respiratory Distress
- target: Abnormal Sweating
- target: Impaired Pain Sensation
- target: Abnormal Autonomic Nervous System Physiology
- target: Corneal Opacity
- target: Decreased Lacrimation
- target: Smooth Tongue
- target: Trismus
phenotypes:
- name: Bowed Long Bones
description: >-
Congenital camptomelia with bowing of the tibia and femur, cortical
thickening, and flared metaphyses with coarsened trabecular pattern.
phenotype_term:
preferred_term: Bowing of the long bones
term:
id: HP:0006487
label: Bowing of the long bones
onset:
onset_category: CONGENITAL
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality.
explanation: >-
Defines congenital long-bone bowing with the characteristic metaphyseal
radiographic pattern as a core feature.
- name: Camptodactyly
description: >-
Congenital finger contractures; a useful prenatal and neonatal clue that
helps distinguish STWS from other bent-bone dysplasias.
phenotype_term:
preferred_term: Camptodactyly
term:
id: HP:0012385
label: Camptodactyly
onset:
onset_category: CONGENITAL
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality.
explanation: >-
Lists camptodactyly among the defining congenital findings.
- name: Neonatal Respiratory Distress
description: >-
Early respiratory failure, often with aspiration, is the leading cause of
death in the first two years.
phenotype_term:
preferred_term: Neonatal respiratory distress
term:
id: HP:0002643
label: Neonatal respiratory distress
onset:
onset_category: NEONATAL
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality.
explanation: >-
Places respiratory distress in the core neonatal phenotype that drives
early lethality.
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mortality rate is higher during the first 2 years (42% <2 years; 10% >2 years) mainly due to respiratory failure, pulmonary arterial hypertension appearing to be a poor prognosis factor (mortality rate 63%).
explanation: >-
Quantifies respiratory failure as the dominant early cause of death.
- name: Feeding Difficulties
description: >-
Swallowing dysfunction and poor feeding frequently require nasogastric or
gastrostomy support in infancy; swallowing often improves after age 2–3
in survivors.
phenotype_term:
preferred_term: Feeding difficulties
term:
id: HP:0011968
label: Feeding difficulties
onset:
onset_category: NEONATAL
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality.
explanation: >-
Feeding difficulties are part of the original molecular series'
defining description.
- reference: PMID:28058407
reference_title: Neuropathies of Stüve-Wiedemann Syndrome due to mutations in leukemia inhibitory factor receptor (LIFR) gene.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
In infants, this can result in respiratory distress, feeding and swallowing difficulties, and hyperthermic episodes.
explanation: >-
Attributes feeding and swallowing failure to the infantile autonomic
phenotype.
- name: Temperature Instability
description: >-
Hyperthermic episodes and poor thermoregulation, often without infection,
are a major cause of sudden death in infancy.
phenotype_term:
preferred_term: Temperature instability
term:
id: HP:0005968
label: Temperature instability
onset:
onset_category: NEONATAL
temporality: RECURRENT
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Stuve-Wiedemann syndrome (SWS) is a severe autosomal recessive condition characterized by bowing of the long bones, with cortical thickening, flared metaphyses with coarsened trabecular pattern, camptodactyly, respiratory distress, feeding difficulties, and hyperthermic episodes responsible for early lethality.
explanation: >-
Hyperthermic episodes are explicitly linked to early lethality.
- reference: PMID:28058407
reference_title: Neuropathies of Stüve-Wiedemann Syndrome due to mutations in leukemia inhibitory factor receptor (LIFR) gene.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
In infants, this can result in respiratory distress, feeding and swallowing difficulties, and hyperthermic episodes.
explanation: >-
Confirms infantile hyperthermic crises as part of the autonomic picture.
- name: Abnormal Sweating
description: >-
Paradoxical or excessive sweating that is not explained by elevated body
temperature, reflecting autonomic sudomotor dysregulation.
phenotype_term:
preferred_term: Hyperhidrosis
term:
id: HP:0000975
label: Hyperhidrosis
evidence:
- reference: PMID:28058407
reference_title: Neuropathies of Stüve-Wiedemann Syndrome due to mutations in leukemia inhibitory factor receptor (LIFR) gene.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Individuals may sweat excessively when body temperature is not elevated.
explanation: >-
Describes temperature-uncoupled sweating, the sudomotor arm of STWS
dysautonomia.
- name: Impaired Pain Sensation
description: >-
Reduced nociception with loss of protective reflexes (corneal blink,
patellar), predisposing to unrecognized injury.
phenotype_term:
preferred_term: Impaired pain sensation
term:
id: HP:0007328
label: Impaired pain sensation
evidence:
- reference: PMID:28058407
reference_title: Neuropathies of Stüve-Wiedemann Syndrome due to mutations in leukemia inhibitory factor receptor (LIFR) gene.
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Additionally, individuals have reduced ability to feel pain and may lose reflexes such as the corneal reflex that normally causes one to blink, and the patellar reflex resulting in the knee-jerk.
explanation: >-
Directly supports reduced pain sensation and lost corneal/patellar
reflexes.
- name: Abnormal Autonomic Nervous System Physiology
description: >-
Composite dysautonomia covering thermoregulation, sweating, swallowing,
breathing, and nociception; the feature that historically separated STWS
from other bent-bone dysplasias and from HSPG2 Schwartz-Jampel syndrome.
phenotype_term:
preferred_term: Dysautonomia
term:
id: HP:0012332
label: Abnormal autonomic nervous system physiology
evidence:
- reference: PMID:27194968
reference_title: "Stüve-Wiedemann Syndrome: Update on Clinical and Genetic Aspects."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Stüve-Wiedemann syndrome is a rare autosomal recessive disorder characterized by bowed long bones, joint restrictions, dysautonomia, and respiratory and feeding difficulties, leading to death in the neonatal period and infancy in several occasions.
explanation: >-
Clinical review lists dysautonomia among the defining features.
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Stuve-Wiedemann syndrome (SWS) is a rare and severe genetic disease characterized by skeletal anomalies and dysautonomic disturbances requiring appropriate care.
explanation: >-
Systematic review frames the disease as skeletal plus dysautonomic.
- name: Scoliosis
description: >-
Progressive spinal deformity in childhood survivors; reported in most
patients older than two years in the 69-patient systematic review.
phenotype_term:
preferred_term: Scoliosis
term:
id: HP:0002650
label: Scoliosis
clinical_course: PROGRESSIVE
frequency: FREQUENT
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
After 2 years, orthopaedic symptoms significantly increase including joint mobility restriction (81%), spinal deformations (77%) and fractures (61%).
explanation: >-
77% spinal deformity among survivors older than two years maps to the
FREQUENT band (30–79%). The estimate is among reported survivors, not
a birth cohort.
- name: Recurrent Fractures
description: >-
Bone fragility with fractures accumulating in childhood survivors as
osteopenia/osteoporosis progresses.
phenotype_term:
preferred_term: Recurrent fractures
term:
id: HP:0002757
label: Recurrent fractures
frequency: FREQUENT
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
After 2 years, orthopaedic symptoms significantly increase including joint mobility restriction (81%), spinal deformations (77%) and fractures (61%).
explanation: >-
61% fracture rate in survivors older than two years maps to FREQUENT.
- name: Pulmonary Arterial Hypertension
description: >-
Uncommon but high-mortality cardiopulmonary complication in infancy.
phenotype_term:
preferred_term: Pulmonary arterial hypertension
term:
id: HP:0002092
label: Pulmonary arterial hypertension
frequency: OCCASIONAL
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mortality rate is higher during the first 2 years (42% <2 years; 10% >2 years) mainly due to respiratory failure, pulmonary arterial hypertension appearing to be a poor prognosis factor (mortality rate 63%).
explanation: >-
Identifies PAH as a poor prognostic factor. Frequency is omitted from
the abstract as a rate among all patients; OCCASIONAL is a conservative
band given that it is discussed as a subset with very high case fatality
rather than a defining feature. Notes below record that the 63% figure
is mortality among those with PAH, not PAH prevalence.
notes: >-
Warnier et al. report 63% mortality among patients with PAH, not a 63%
prevalence of PAH. Do not treat the 63% figure as a phenotype frequency.
- name: Joint Stiffness
description: >-
Restricted joint mobility that worsens with age in survivors.
phenotype_term:
preferred_term: Joint stiffness
term:
id: HP:0001387
label: Joint stiffness
clinical_course: PROGRESSIVE
frequency: VERY_FREQUENT
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
After 2 years, orthopaedic symptoms significantly increase including joint mobility restriction (81%), spinal deformations (77%) and fractures (61%).
explanation: >-
81% joint-mobility restriction after age 2 maps to VERY_FREQUENT
(80–99%), with the same survivor-ascertainment caveat.
- reference: PMID:27194968
reference_title: "Stüve-Wiedemann Syndrome: Update on Clinical and Genetic Aspects."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Stüve-Wiedemann syndrome is a rare autosomal recessive disorder characterized by bowed long bones, joint restrictions, dysautonomia, and respiratory and feeding difficulties, leading to death in the neonatal period and infancy in several occasions.
explanation: >-
Independent review lists joint restrictions among core features.
- name: Osteopenia
description: >-
Low bone mineral density that accumulates in childhood survivors and
underlies the fracture burden already curated as Recurrent Fractures.
phenotype_term:
preferred_term: Osteopenia
term:
id: HP:0000938
label: Osteopenia
frequency: FREQUENT
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Osteoporosis prevalence also increases in children
explanation: >-
The same paragraph gives the split 11% <2 years / 48% ≥2 years.
The ≥2-year 48% maps to FREQUENT (30–79%), matching how scoliosis
and fractures in this entry use the survivor denominator. Total-cohort
Table 4 is 19/69 (28%).
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
performed at 5 weeks of age showed diffuse hypomineralization of bones, indicating osteopenia
explanation: >-
Radiographic osteopenia in a genetically confirmed LIFR infant.
- name: Growth Delay
description: >-
Postnatal growth retardation, reported in most of the total cohort and
in nearly all survivors older than two years.
phenotype_term:
preferred_term: Growth delay
term:
id: HP:0001510
label: Growth delay
frequency: FREQUENT
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Other osteo-articular manifestations reported in more than the half of the total cohort are camptodactyly (80%), any degree of joint mobility restriction (65%), growth retardation (57%) and feet malposition (51%).
explanation: >-
57% growth retardation in the total cohort maps to FREQUENT. Table 4
gives 87% among ≥2-year survivors (VERY_FREQUENT in that subset).
- name: Talipes
description: >-
Congenital foot malposition (clubfoot/talipes spectrum), present in about
half of reported patients.
phenotype_term:
preferred_term: Talipes
term:
id: HP:0001883
label: Talipes
onset:
onset_category: CONGENITAL
frequency: FREQUENT
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Other osteo-articular manifestations reported in more than the half of the total cohort are camptodactyly (80%), any degree of joint mobility restriction (65%), growth retardation (57%) and feet malposition (51%).
explanation: >-
51% feet malposition maps to FREQUENT; Talipes is the closest HP class
for that radiographic/clinical bundle.
- name: Corneal Opacity
description: >-
Corneal ulcers progressing to opacity from hypolacrimation and absent
corneal reflex; the dominant ocular complication in childhood survivors.
phenotype_term:
preferred_term: Corneal opacity
term:
id: HP:0007957
label: Corneal opacity
frequency: FREQUENT
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The main ophthalmologic complications reported are corneal ulcers and consecutive opacities (8%/45%) due to hypolacrimation (13%/26%) and a lack of corneal reflex/corneal anesthesia (10%/48%).
explanation: >-
The paired percentages are the <2-year / ≥2-year split; 8% is the
<2-year subgroup, pulled down by infant deaths before ocular disease
is ascertained, and Table 5's total-cohort figure is 26% (18/69).
The ≥2-year 45% maps to FREQUENT.
- name: Decreased Lacrimation
description: >-
Hypolacrimation contributing to corneal injury together with absent
blink/corneal reflex.
phenotype_term:
preferred_term: Decreased lacrimation
term:
id: HP:0000633
label: Decreased lacrimation
frequency: OCCASIONAL
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
The main ophthalmologic complications reported are corneal ulcers and consecutive opacities (8%/45%) due to hypolacrimation (13%/26%) and a lack of corneal reflex/corneal anesthesia (10%/48%).
explanation: >-
The paper's paired percentages are the <2-year / ≥2-year split
(13%/26%), both of which map to OCCASIONAL (5–29%). Table 5's
total-cohort hypolacrimation is 19%, also OCCASIONAL.
- name: Smooth Tongue
description: >-
Smooth tongue with reduced fungiform papillae, often with self-injury
after tooth eruption because of impaired pain sensation.
phenotype_term:
preferred_term: Smooth tongue
term:
id: HP:0010298
label: Smooth tongue
frequency: FREQUENT
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Stomatological manifestations included a smooth tongue with lack of fungiform papillae (5%/61%)
explanation: >-
The paired percentages are the <2-year / ≥2-year split. 61% among
≥2-year survivors maps to FREQUENT, matching the survivor-denominator
convention used for scoliosis and fractures in this entry.
- name: Hypotonia
description: >-
Generalized hypotonia, reported in more than half of published patients.
phenotype_term:
preferred_term: Hypotonia
term:
id: HP:0001252
label: Hypotonia
frequency: FREQUENT
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Neurological manifestations encountered in SWS include hypotonia (71%/45%), trismus or myotonia (21%/36%)
explanation: >-
Paired percentages are the <2-year / ≥2-year split. Table 5 total-cohort
hypotonia is 41/69 (59%), which maps to FREQUENT. The ≥2-year figure
is 45%, also FREQUENT.
- name: Trismus
description: >-
Restricted mouth opening (trismus/myotonia), contributing to feeding
difficulty and historically to confusion with Schwartz-Jampel syndrome.
phenotype_term:
preferred_term: Trismus
term:
id: HP:0000211
label: Trismus
frequency: OCCASIONAL
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Neurological manifestations encountered in SWS include hypotonia (71%/45%), trismus or myotonia (21%/36%)
explanation: >-
Paired percentages are the <2-year / ≥2-year split (21%/36%). Table 5
total-cohort trismus/myotonia is 19/69 (28%), mapping to OCCASIONAL
(5–29%). The ≥2-year 36% would be FREQUENT; this entry uses the
total-cohort figure here, as for hypotonia's 59% band, and records
the split so the mixture is deliberate.
- name: Intrauterine Growth Retardation
description: >-
Prenatal growth restriction, reported in 17% of the assembled cohort;
more than half of pregnancies had normal prenatal growth.
phenotype_term:
preferred_term: Intrauterine growth retardation
term:
id: HP:0001511
label: Intrauterine growth retardation
onset:
onset_category: ANTENATAL
frequency: OCCASIONAL
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Intra-uterine growth restriction was found in 17% of patients while a normal prenatal growth is reported in more than half of the cohort.
explanation: >-
17% maps to OCCASIONAL (5–29%). Table 2 is 12/69.
- name: Oligohydramnios
description: >-
Reduced amniotic fluid as an inconstant prenatal ultrasound finding,
reported in 16% of the cohort and easily missed as a standalone clue.
phenotype_term:
preferred_term: Oligohydramnios
term:
id: HP:0001562
label: Oligohydramnios
onset:
onset_category: ANTENATAL
frequency: OCCASIONAL
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Another inconstant ultrasound findings include talipes, camptodactyly, intra-uterine growth restriction and oligoamnios
explanation: >-
Names oligohydramnios among the inconstant prenatal ultrasound
findings. Table 2 quantifies it at 11/69 (16%), OCCASIONAL.
genetic:
- name: LIFR
gene_term:
preferred_term: LIFR
term:
id: hgnc:6597
label: LIFR
presence: PRESENT
relationship_type: CAUSATIVE
variant_origin: GERMLINE
inheritance:
- name: Autosomal recessive inheritance
inheritance_term:
preferred_term: Autosomal recessive inheritance
term:
id: HP:0000007
label: Autosomal recessive inheritance
notes: >-
Most reported alleles are truncating (frameshift, nonsense, splice). A
recurrent c.653dup / 653_654insT founder frameshift is described in
families from the United Arab Emirates (PMID:14740318).
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We conclude, therefore, that SWS and SJS2 represent a single clinically and genetically homogeneous condition due to null mutations in the LIFR gene on chromosome 5p13.
explanation: >-
Establishes LIFR null alleles as the cause of both STWS and the
historical SJS type 2 label.
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
An identical frameshift insertion (653_654insT) was identified in families from the United Arab Emirates, suggesting a founder effect in that region.
explanation: >-
Documents the UAE founder frameshift.
treatments:
- name: Supportive Care
description: >-
There is no disease-modifying standard therapy. Care is multidisciplinary
and symptomatic: airway and ventilatory support, assisted feeding,
structured management of hyperthermic crises, aspiration precautions,
and later orthopedic and ophthalmologic surveillance.
therapeutic_modality: OTHER
treatment_term:
preferred_term: Supportive Care
term:
id: NCIT:C15747
label: Supportive Care
evidence:
- reference: PMID:24618404
reference_title: "Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
STWS is managed on a symptomatic basis since there is no treatment currently available.
explanation: >-
States that management is symptomatic and that no disease-modifying
therapy exists.
- name: Nasogastric Feeding
description: >-
Short-term enteral support for neonatal swallowing failure and aspiration
risk; often a bridge to gastrostomy when oral skills do not progress.
therapeutic_modality: DEVICE
treatment_term:
preferred_term: nasogastric intubation
term:
id: NCIT:C91836
label: Nasogastric Intubation
target_phenotypes:
- preferred_term: Feeding difficulties
term:
id: HP:0011968
label: Feeding difficulties
evidence:
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Increased caution should be paid towards managing swallowing difficulties with nasogastric tube placement or gastrostomy especially during the first few years of life
explanation: >-
Names nasogastric tube placement as a first-years feeding intervention
for swallowing failure.
- name: Gastrostomy
description: >-
Surgical feeding tube when prolonged enteral support is required for
dysphagia and aspiration prevention.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: gastrostomy tube procedure
term:
id: NCIT:C157864
label: Gastrostomy Tube Procedure
target_phenotypes:
- preferred_term: Feeding difficulties
term:
id: HP:0011968
label: Feeding difficulties
evidence:
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Increased caution should be paid towards managing swallowing difficulties with nasogastric tube placement or gastrostomy especially during the first few years of life
explanation: >-
Names gastrostomy alongside nasogastric feeding as the swallowing
intervention used in the first years of life.
- name: Physical Therapy
description: >-
Conservative orthopedic management of progressive contractures, bowing,
and spinal deformity in survivors, often with bracing.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: physical therapy
term:
id: NCIT:C15302
label: Physical Therapy
target_phenotypes:
- preferred_term: Joint stiffness
term:
id: HP:0001387
label: Joint stiffness
- preferred_term: Scoliosis
term:
id: HP:0002650
label: Scoliosis
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Conservative and preventive management include physiotherapy and the use of braces.
explanation: >-
Systematic review names physiotherapy and bracing as conservative
orthopedic management in survivors.
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Many long-term survivors require physical therapy and braces
explanation: >-
Independent case-and-review states that long-term survivors require
physical therapy and braces.
- name: Bromocriptine
description: >-
Dopamine-agonist rescue for central hyperthermia unresponsive to
antipyretics. Documented in a genetically confirmed childhood survivor
as part of a home fever plan; use in STWS is case-level, not a
controlled indication.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: bromocriptine
term:
id: CHEBI:3181
label: bromocriptine
target_phenotypes:
- preferred_term: Temperature instability
term:
id: HP:0005968
label: Temperature instability
target_mechanisms:
- target: Autonomic and Sensory Neuron Dysfunction
treatment_effect: MODULATES
description: >-
Used to abort dysautonomic hyperthermic crises after first-line
antipyretics fail.
evidence:
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
use of gabapentin and bromocriptine for pain and hyperthermia management respectively in patients with SWS, which should be studied in future case reports and series
explanation: >-
Authors report bromocriptine for hyperthermia in this LIFR-confirmed
survivor and explicitly call for further study, so the claim is
PARTIAL rather than established efficacy.
evidence:
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
bromocriptine if there is no response. Bromocriptine is a dopamine receptor agonist that has been used for treating hyperpyrexia in Neuroleptic Malignant Syndrome (NMS) and other hyperthermia of central origin
explanation: >-
Describes the patient's stepwise fever plan (acetaminophen/ibuprofen,
then bromocriptine) and the pharmacological rationale.
- name: Gabapentin
description: >-
Used for pain management in a genetically confirmed childhood survivor.
Case-level only; authors ask for further reports.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
therapeutic_agent:
- preferred_term: gabapentin
term:
id: CHEBI:42797
label: gabapentin
target_phenotypes:
- preferred_term: Impaired pain sensation
term:
id: HP:0007328
label: Impaired pain sensation
evidence:
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
use of gabapentin and bromocriptine for pain and hyperthermia management respectively in patients with SWS, which should be studied in future case reports and series
explanation: >-
Names gabapentin for pain in STWS and flags the evidence as needing
further study.
- name: Corneal lubrication
description: >-
Artificial tears, ointments, and contact lenses to protect an anesthetic,
hypolacrimating cornea; surgical adjuncts (punctal occlusion,
tarsorrhaphy) are used when conservative measures fail. No specific NCIT
clinical-action term was a better fit than this free-text preferred term.
therapeutic_modality: OTHER
treatment_term:
preferred_term: corneal lubrication with artificial tears and ointments
target_phenotypes:
- preferred_term: Corneal opacity
term:
id: HP:0007957
label: Corneal opacity
- preferred_term: Decreased lacrimation
term:
id: HP:0000633
label: Decreased lacrimation
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Management includes artificial drops and ointments or surgical procedures (punctual occlusion, lateral tarsorrhaphy, optical iridectomy)
explanation: >-
Systematic review names artificial drops/ointments as first-line
ocular protection, with surgical options if needed.
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
She received close ocular follow-up and treatment with artificial tears, ointments and contact lens since the neonatal period
explanation: >-
Index-patient narrative in the same review documents neonatal-onset
lubrication as actual care delivered.
- name: Bisphosphonate therapy with vitamin D and calcium
description: >-
Antiresorptive plus mineral/vitamin D support used in survivors to
reduce recurrent fractures and progressive osteopenia. Not a
disease-modifying LIFR therapy; evidence is observational.
therapeutic_modality: SMALL_MOLECULE
treatment_term:
preferred_term: Bisphosphonate Therapy
term:
id: NCIT:C198585
label: Bisphosphonate Therapy
therapeutic_agent:
- preferred_term: vitamin D
term:
id: CHEBI:27300
label: vitamin D
- preferred_term: calcium(2+)
term:
id: CHEBI:29108
label: calcium(2+)
target_phenotypes:
- preferred_term: Recurrent fractures
term:
id: HP:0002757
label: Recurrent fractures
- preferred_term: Osteopenia
term:
id: HP:0000938
label: Osteopenia
target_mechanisms:
- target: Impaired Chondrogenesis and Bone Remodeling
treatment_effect: INHIBITS
description: >-
Bisphosphonates suppress osteoclast-mediated resorption that this
node records as increased.
evidence:
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
incorporating the use of bisphosphonates, vitamin D and calcium in the medical regimen to control recurrent fractures and accelerated osteoporosis
explanation: >-
Names bisphosphonates plus vitamin D and calcium as the regimen
used to control fractures and accelerated osteoporosis.
evidence:
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
incorporating the use of bisphosphonates, vitamin D and calcium in the medical regimen to control recurrent fractures and accelerated osteoporosis
explanation: >-
Independent review of a genetically confirmed survivor restates the
same antiresorptive-plus-mineral regimen.
- name: Orthopedic surgery
description: >-
Repeated osteotomies for progressive limb bowing (telescopic
Fassier-Duval rodding recommended to reduce recurrence) and surgical
stabilization of scoliosis. Deformity often recurs; surgery is
reconstructive, not curative.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: orthopedic surgical procedure
term:
id: NCIT:C16186
label: Orthopedic Surgical Procedure
target_phenotypes:
- preferred_term: Bowing of the long bones
term:
id: HP:0006487
label: Bowing of the long bones
- preferred_term: Scoliosis
term:
id: HP:0002650
label: Scoliosis
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Surgical stabilization of scoliosis is often required, while osteotomies are performed to reduced limbs deformities
explanation: >-
Names scoliosis stabilization and limb osteotomy as the typical
surgical program. The source spelling is "to reduced".
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
recommend the use of telescopic intramedullary rodding (Fassier-Duval rods) to reduce the risk of recurrence and the need for multiple surgeries
explanation: >-
Cites the Fassier-Duval telescopic-rod recommendation for recurrent
limb deformity.
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Many long-term survivors require physical therapy and braces, as well as osteotomies to reduce limb deformities and surgical stabilization of scoliosis
explanation: >-
Confirms osteotomy and scoliosis stabilization as expected care in
long-term survivors.
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
bilateral femoral valgus osteotomy, which was performed at three years of age
explanation: >-
Documents an actual femoral valgus osteotomy in the genetically
confirmed childhood survivor.
- name: Genetic Counseling
description: >-
Autosomal recessive counseling, cascade carrier testing, and reproductive
options (prenatal diagnosis, PGT-M) after identification of familial LIFR
variants. Particularly relevant in founder populations.
therapeutic_modality: OTHER
treatment_term:
preferred_term: genetic counseling
term:
id: NCIT:C15240
label: Genetic Counseling
evidence:
- reference: PMID:38628360
reference_title: "A novel termination site in a case of Stüve-Wiedemann syndrome: case report and review of literature."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
This case adds to the literature surrounding rare instances of childhood survivors of SWS and raises awareness for this syndrome to facilitate an earlier recognition, intervention, and genetic counseling for the families, thereby improving understanding of this disease and the health outcomes for the children affected by this condition.
explanation: >-
Explicitly names genetic counseling as part of clinical management.
prevalence:
- population: Published cases
measure_type: CASES_IN_LITERATURE
prevalence_class: ULTRA_RARE
notes: >-
Warnier et al. 2022 systematically reviewed 69 published patients; no
general-population incidence was recovered. Orphanet ORPHA:3206 could not
be cited from the structured cache in this worktree.
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
In our cohort of 69 patients, the median age at report was 32 months.
explanation: >-
Gives the size of the assembled published-case literature rather than a
population rate.
- population: Worldwide
measure_type: UNKNOWN
prevalence_class: RARE
notes: >-
Qualitative "rare" descriptor from reviews; no denominator-based
worldwide rate was recovered from cached abstracts.
evidence:
- reference: PMID:24618404
reference_title: "Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology."
supports: SUPPORT
evidence_source: OTHER
snippet: >-
Stüve-Wiedemann syndrome (STWS; OMIM # 610559) is a rare bent-bone dysplasia that includes radiologic bone anomalies, respiratory distress, feeding difficulties, and hyperthermic episodes.
explanation: >-
Qualitative rarity statement. OMIM number in this abstract is the known
# 610559 typo; phenotype identity is LIFR-related STWS.
progression:
- phase: Neonatal and infantile high-mortality phase
age_range: Birth to 2 years
notes: >-
Birth through age 2 is dominated by dysautonomic respiratory failure,
aspiration, and hyperthermic crises. Warnier et al. report 42% mortality
before age 2 versus 10% after age 2.
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Mortality rate is higher during the first 2 years (42% <2 years; 10% >2 years) mainly due to respiratory failure, pulmonary arterial hypertension appearing to be a poor prognosis factor (mortality rate 63%).
explanation: >-
Quantifies the early-mortality natural history.
- phase: Childhood orthopedic accumulation in survivors
age_range: After 2 years
notes: >-
After age 2, dysautonomia often lessens while joint restriction, spinal
deformity, and fractures increase.
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
After 2 years, orthopaedic symptoms significantly increase including joint mobility restriction (81%), spinal deformations (77%) and fractures (61%).
explanation: >-
Describes the survivor natural-history shift toward orthopedic disease.
diagnosis:
- name: Molecular genetic testing of LIFR
description: >-
Identification of biallelic pathogenic LIFR variants confirms the
diagnosis in a neonate or child with bent bones plus dysautonomia.
diagnosis_term:
preferred_term: molecular genetic testing
term:
id: NCIT:C19770
label: Molecular Analysis
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We conclude, therefore, that SWS and SJS2 represent a single clinically and genetically homogeneous condition due to null mutations in the LIFR gene on chromosome 5p13.
explanation: >-
Establishes LIFR sequencing as the molecular definition of the disease.
- name: Clinical diagnostic criteria
description: >-
Clinical diagnosis rests on the association of short bowed long bones
with a dysautonomic pattern, not on skeletal findings alone.
diagnosis_term:
preferred_term: Physical Examination
term:
id: NCIT:C20989
label: Physical Examination
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Clinical diagnosis criteria includes the association of skeletal involvement with short and bowed long bones, and a dysautonomic pattern.
explanation: >-
States the clinical diagnostic pairing of bent bones plus dysautonomia.
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Long bones: short and bowed (mandatory criterion for diagnosis)
explanation: >-
Table 6 reporting framework marks short bowed long bones as mandatory
for the diagnosis.
- name: Skeletal survey
description: >-
Whole-skeleton radiographs showing bowed femur and tibia with diaphyseal
cortical thickening at the concavity and enlarged metaphyses distinguish
STWS from campomelic dysplasia (scapular/pelvic involvement).
diagnosis_term:
preferred_term: Diagnostic Imaging Testing
term:
id: NCIT:C16502
label: Diagnostic Imaging Testing
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
enlarged metaphysis and diaphyseal cortical thickening at the concavity of long bones are suggestive of SWS
explanation: >-
Radiographic discriminator used both for diagnosis and against
campomelic dysplasia.
animal_models:
- name: Lifr-null mouse
species: Mouse
genotype: Lifr targeted disruption (homozygous null)
publication: PMID:7789261
description: >-
Homozygous Lifr knockout mice have placental, skeletal, neural and
metabolic defects and die on the day of birth. Fetal bone volume is
reduced more than three-fold with a six-fold increase in osteoclasts
and severe perinatal osteopenia; astrocyte numbers are reduced in
spinal cord and brainstem.
genes:
- preferred_term: LIFR
term:
id: hgnc:6597
label: LIFR
modeled_mechanisms:
- target: Impaired Chondrogenesis and Bone Remodeling
relationship: RECAPITULATES
fidelity: MODERATE
description: >-
Recapitulates low bone volume, osteoclast excess, and osteopenia.
limitations: >-
Perinatal lethality precludes modeling of the childhood survivor
orthopedic phenotype (progressive scoliosis, recurrent fractures).
evidence:
- reference: PMID:7789261
reference_title: Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Fetal bone volume is reduced greater than three-fold and the number of osteoclasts is increased six-fold, resulting in severe osteopenia of perinatal bone.
explanation: >-
Direct skeletal readout of the remodeling node.
- target: Autonomic and Sensory Neuron Dysfunction
relationship: PARTIALLY_RECAPITULATES
fidelity: LOW
description: >-
Neural developmental defects (reduced astrocytes) support a nervous-system
requirement for LIFR but do not reproduce human dysautonomic crises.
limitations: >-
The mouse dies on the day of birth and does not exhibit the human
infantile hyperthermic, swallowing, and sweating phenotype that
dominates clinical care.
evidence:
- reference: PMID:7789261
reference_title: Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Astrocyte numbers are reduced in the spinal cord and brain stem.
explanation: >-
Neural cellular deficit, not a demonstration of human-like
dysautonomia.
evidence:
- reference: PMID:7789261
reference_title: Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Pleiotropic defects in the mutant animals preclude survival beyond the day of birth.
explanation: >-
States perinatal lethality, the main translational limitation of this
model.
differential_diagnoses:
- name: Schwartz-Jampel syndrome (HSPG2/perlecan)
description: >-
Historical "SJS type 2" was STWS. True Schwartz-Jampel syndrome is the
HSPG2/perlecan chondrodystrophic myotonia with mask-like face and
neuromyotonia, not LIFR dysautonomia.
distinguishing_features:
- Causal gene HSPG2 rather than LIFR
- Myotonia/neuromyotonia from AChE-anchor failure, not JAK/STAT3 loss
- No hyperthermic dysautonomic lethality as the defining course
evidence:
- reference: PMID:14740318
reference_title: Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We conclude, therefore, that SWS and SJS2 represent a single clinically and genetically homogeneous condition due to null mutations in the LIFR gene on chromosome 5p13.
explanation: >-
Separates historical SJS type 2 (now STWS/LIFR) from HSPG2 SJS.
- name: Campomelic dysplasia (SOX9)
description: >-
Another ISDS bent-bone dysplasia. Distinguished by SOX9-related scapular
hypoplasia, 11 pairs of ribs, sex reversal in many 46,XY infants, and
absence of LIFR-type dysautonomia.
distinguishing_features:
- Causal gene SOX9 rather than LIFR
- Hypoplastic scapulae and 11 rib pairs
- 46,XY sex reversal in many affected infants
evidence:
- reference: PMID:35461249
reference_title: "Clinical overview and outcome of the Stuve-Wiedemann syndrome: a systematic review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Involvement of scapulae and pelvis is typical of CD, since enlarged metaphysis and diaphyseal cortical thickening at the concavity of long bones are suggestive of SWS
explanation: >-
Contrasts campomelic dysplasia's scapular/pelvic involvement with the
STWS long-bone concavity pattern.
- name: IL6ST-Related Stuve-Wiedemann Syndrome (extended STWS)
disease_term:
preferred_term: Stuve-Wiedemann syndrome 2
term:
id: MONDO:0030756
label: Stuve-Wiedemann syndrome 2
description: >-
Complete GP130 (IL6ST) loss causes a lethal Stuve-Wiedemann-like skeletal
and neonatal lung phenotype plus thrombocytopenia, dermatitis, renal
anomalies, and defective acute-phase response. Broader cytokine failure
than LIFR-null STWS1.
distinguishing_features:
- Causal gene IL6ST rather than LIFR
- Absent responses to IL-6, IL-11, IL-27, OSM, and LIF
- Extra-skeletal immune, hematologic, cutaneous, and renal features
evidence:
- reference: PMID:31914175
reference_title: Absence of GP130 cytokine receptor signaling causes extended Stüve-Wiedemann syndrome.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
We describe three unrelated families with at least five affected individuals who presented with lethal Stüve-Wiedemann-like syndrome characterized by skeletal dysplasia and neonatal lung dysfunction with additional features such as congenital thrombocytopenia, eczematoid dermatitis, renal abnormalities, and defective acute-phase response.
explanation: >-
Defines the IL6ST phenocopy as an extended, broader syndrome rather than
classic LIFR STWS1.
discussions:
- discussion_id: stws1_lifr_mouse_perinatal_mismatch
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- pathophysiology#Impaired Chondrogenesis and Bone Remodeling
- pathophysiology#Autonomic and Sensory Neuron Dysfunction
prompt: >-
How faithfully does perinatal-lethal Lifr-null mouse osteopenia and
astrocyte loss represent the human STWS1 natural history, in which some
patients survive infancy with accumulating orthopedic disease as
dysautonomia lessens?
rationale: >-
Ware et al. 1995 show that homozygous Lifr disruption is lethal on the
day of birth, with reduced fetal bone volume and reduced astrocytes.
Human STWS1 has high but not universal infant mortality (42% before age
2 in Warnier et al.), and survivors have a distinct later phenotype the
mouse cannot reach. The skeletal remodeling direction is concordant; the
autonomic crisis phenotype and childhood course are not demonstrated in
the mouse.
proposed_experiments:
- experiment_id: exp_stws1_conditional_lifr_postnatal
name: Conditional or hypomorphic Lifr alleles with postnatal survival
description: >-
Generate conditional or hypomorphic Lifr alleles that permit postnatal
survival, then perform thermoregulatory, swallowing, and serial skeletal
phenotyping aligned to the human two-phase natural history (infant
dysautonomia, then childhood orthopedic accumulation).
experiment_type:
preferred_term: conditional gene knockout
evidence:
- reference: PMID:7789261
reference_title: Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: >-
Pleiotropic defects in the mutant animals preclude survival beyond the day of birth.
explanation: >-
Documents the perinatal-lethality mismatch with human survivors.